These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 9110097)

  • 1. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings.
    Rush AJ; Schlesser MA; Roffwarg HP; Giles DE; Orsulak PJ; Fairchild C
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):23-9. PubMed ID: 6409892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of biologic markers in a general hospital affective disorders program.
    Lieber AL; Newbury N
    J Clin Psychiatry; 1985 Jun; 46(6):217-21. PubMed ID: 3922959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine abnormalities in affective disorders.
    Extein I; Pottash AL; Gold MS
    Encephale; 1982; 8(2):203-11. PubMed ID: 6809445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
    Targum SD
    Biol Psychiatry; 1983 Jan; 18(1):3-19. PubMed ID: 6403062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorders.
    Rush AJ; Giles DE; Roffwarg HP; Parker CR
    Biol Psychiatry; 1982 Mar; 17(3):327-41. PubMed ID: 7082700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
    D'Haenen H; Kaufman L; De Weert D; Cornet C; Raets I
    Acta Psychiatr Belg; 1984; 84(3):228-34. PubMed ID: 6435395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the Newcastle scale and sleep polysomnographic variables in major depression: a controlled study.
    Hubain PP; Souery D; Jönck L; Staner L; Van Veeren C; Kerkhofs M; Mendlewicz J; Linkowski P
    Eur Neuropsychopharmacol; 1995 Jun; 5(2):129-34. PubMed ID: 7549455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse.
    Targum SD
    Biol Psychiatry; 1984 Mar; 19(3):305-18. PubMed ID: 6426529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine and sleep variables in major depressed inpatients: role of severity.
    Hubain P; Van Veeren C; Staner L; Mendlewicz J; Linkowski P
    Psychiatry Res; 1996 Jun; 63(1):83-92. PubMed ID: 8832777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test and unipolar/bipolar distinctions.
    Zisook S; Janowsky DS; Overall JE; Risch SC
    J Clin Psychiatry; 1985 Nov; 46(11):461-5. PubMed ID: 4055705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone suppression test results in delusional versus nondelusional depression: preliminary evidence of distinct clinical entities.
    Kraus RP; Remick RA
    J Clin Psychiatry; 1985 May; 46(5):188-90. PubMed ID: 3988719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of the dexamethasone test in the differential diagnosis of depressive states].
    Nuller IuL; Ostroumova MN; Gordon OI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):547-51. PubMed ID: 3716705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biologic diagnosis of depression by the TRH and dexamethasone tests].
    Chabrol H; Moron P
    Encephale; 1983; 9(1):1-22. PubMed ID: 6135596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRH stimulation and dexamethasone suppression in borderline personality disorder.
    De la Fuente JM; Mendlewicz J
    Biol Psychiatry; 1996 Sep; 40(5):412-8. PubMed ID: 8874844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and subtyping of depressive disorders by quantitative electroencephalography: III. Discriminating unipolar from bipolar depression.
    Lieber AL; Newbury ND
    Hillside J Clin Psychiatry; 1988; 10(2):165-72. PubMed ID: 3147236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, neuroendocrine, and sleep EEG diagnosis of "unusual" affective presentations: a practical review.
    Akiskal HS; Lemmi H
    Psychiatr Clin North Am; 1983 Mar; 6(1):69-83. PubMed ID: 6412218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.